Discovery of a novel, selective brain penetrant CDK2 inhibitor for targeted cancer therapy Oct 24 Written by Sergey Kostikov Download Poster Sergey Kostikov Previous Previous ZE74-0282 is a novel JAK2 JH2 domain inhibitor with promising preclinical activity in JAK2V617F mutant diseases
Discovery of a novel, selective brain penetrant CDK2 inhibitor for targeted cancer therapy Oct 24 Written by Sergey Kostikov Download Poster Sergey Kostikov
